Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biosof Biyoteknoloji is a Turkish biotechnology company specializing in the development and manufacture of advanced molecular diagnostic solutions. Founded in 2015 and based in Istanbul, the company focuses on producing high-quality real-time PCR kits and automated DNA/RNA extraction systems for clinical and research laboratories. Their product portfolio, marketed under the B-SOF brand, covers a wide range of infectious diseases, including respiratory pathogens, blood-borne viruses, and sexually transmitted infections. Biosof aims to provide localized, cost-effective biotech tools to the Middle Eastern and European markets, supporting rapid and accurate disease detection. The company also offers laboratory reagents and technical consultancy services to enhance diagnostic capabilities in healthcare settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biosof.